High-quality human umbilical cord-derived mesenchymal stem cells (hUC-MSC), produced from our proprietary technology platforms, possess superior therapeutic potential to regulate immune system, inhibit inflammation and promote the recovery of injured and diseased tissues. Our hUC-MSC drug delivery system utilizes the precise targeting ability of hUC-MSC to increase the delivery efficiency while reduce the off-target side effects of systemically administered medicines.

​

We have applied our proprietary stem cell technology platform to build what we believe is the most advanced stem cell-based product portfolio in the industry. Our technology platform has the potential to address multiple incurable diseases with significant unmet market needs.